(Q44775116)

6 December 2017

title

Bystander elimination of antigen loss variants in established tumors (English)

1 reference

6 December 2017

Michael T Spiotto

1

1 reference

6 December 2017

Donald A Rowley

series ordinal

2

1 reference

6 December 2017

Hans Schreiber

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

22 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

10

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

294-298

1 reference

Human tumor antigens recognized by T lymphocytes

6 December 2017

cites work

1 reference

7 January 2021

The clonal evolution of tumor cell populations

1 reference

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

7 January 2021

Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens

1 reference

7 January 2021

Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation

1 reference

7 January 2021

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

1 reference

7 January 2021

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

1 reference

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

7 January 2021

Eradication of established tumors by CD8+ T cell adoptive immunotherapy

1 reference

7 January 2021

Multiple cancers. Tumor burden permits the outgrowth of other cancers

1 reference

7 January 2021

Inducible site-directed recombination in mouse embryonic stem cells

1 reference

7 January 2021

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells

1 reference

7 January 2021

Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.

1 reference

7 January 2021

Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization

1 reference

7 January 2021

A cytotoxic T lymphocyte clone can recognize the same naturally occurring self peptide in association with a self and nonself class I MHC protein

1 reference

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

7 January 2021

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

1 reference

7 January 2021

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

7 January 2021

Cross-presentation of tumor antigens to effector T cells is sufficient to mediate effective immunotherapy of established intracranial tumors

1 reference

7 January 2021

Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway

1 reference

7 January 2021

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

1 reference

7 January 2021

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

1 reference

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM999

1 reference

6 December 2017

1 reference